Fusion protein of equine influenza virus h3n8 subtype and its preparation method, application and vaccine

A fusion protein, H3N8 technology, applied in antiviral immunoglobulin, veterinary vaccines, biochemical equipment and methods, etc., to achieve high expression, good antigenicity, and wide application range

A fusion protein, H3N8 technology, applied in antiviral immunoglobulin, veterinary vaccines, biochemical equipment and methods, etc., to achieve high expression, good antigenicity, and wide application range

CN109180820BActive Publication Date: 2021-06-25天康生物制药有限公司

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion protein of equine influenza virus h3n8 subtype and its preparation method, application and vaccine
  • Fusion protein of equine influenza virus h3n8 subtype and its preparation method, application and vaccine
  • Fusion protein of equine influenza virus h3n8 subtype and its preparation method, application and vaccine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0047] The present invention also provides a method of preparing the above fusion protein, the preparation method, by expressing the gene of the fusion protein in the host, for example, but is, but is not limited to, in E. coli expression system, yeast expression system, insect expression The system, plant expression system, or mammalian expression system can, due to the protein expressed by mammalian cells, the structure and biological characteristics are closer to the natural protein, and thus the present invention preferably uses a mammalian expression system to express the fusion. The gene of the protein is more preferably using a gene of a CHO cell expression system to express the fusion protein. CHO cells are Chinese hamster ovary, and CHO cell expression systems have the following advantages:

[0048] (1) With accurate translational folding and modification function, expressed proteins are closest to natural proteins molecules in molecular structures, physicochemical proper...

Embodiment 1

[0068] Example 1: HA-NA gene design and synthesis

[0069] HA-NA gene design and synthesis: HA gene (GenBank login number KX815377.1) After optimization, the design length 810bp has sequences shown in SEQ ID NO.1; NA gene (GenBank login number MG132049.1) is optimized The design length is 900 bp and has the sequence shown in SEQ ID NO.2. The HA gene is connected to the NA gene, and the Linker sequence has a sequence shown in SEQ ID NO. The HA-NA gene is 1740 bp, which has an amino acid sequence as shown in SEQ ID NO.4 and a nucleotide sequence as indicated by SEQ ID NO. HA-NA gene was completed by Shanghai University of Furious Bio.

Embodiment 2

[0070] Example 2: PEE6.4-HA-NA recombinant plasmid construction

[0071] 2. Add Enzyme Substation: Addition of Enzyme Substances by PCR amplification at the upstream and downstream of the HA-NA gene sequence: HindII, SMAI, PCR amplification upstream primers such as SEQ ID NO.6, PCR amplification downstream The primers are shown in SEQ ID NO. 7. PEE6.4-HA-NA plasmid spectrum figure 1 Indicated.

[0072] 2.2HA-NA gene and carrier double enzyme digestion

[0073] 2.2.1 Constructing 50 μl of the reaction system, and mixed the components at 37 ° C for 2 h after mixing each component.

[0074]

[0075]

[0076] 2.2.2 Objective DNA fragment recycling: DNA gel recovery kit (purchased from Beijing Laibao Technology Co., Ltd.), recovered fragment, steps as follows:

[0077] (1) After agarose gel electrophoresis, the destination DNA strip was carefully cut from the agarose gel, and in the 1.5 ml EP tube, weigh weight.

[0078] (2) Add 3x volume sol liquid to the EP tube, 50-55 ° C water ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a fusion protein of equine influenza virus H3N8 subtype, its preparation method, application and vaccine, and relates to the field of biotechnology. The fusion protein connects the sequences of the HA gene and the NA gene of the equine influenza virus H3N8 subtype in series, and the expressed fusion protein has the advantages of good antigenicity and high expression amount. The fusion protein can be applied to the preparation of vaccines, antibodies and kits for detecting equine influenza virus. The vaccine containing the fusion protein has better immunogenicity, can produce higher antibody titer after immunizing animals, and enables animals to obtain better protection effect.

Description

Technical field [0001] The present invention relates to the field of biotechnology, and more particularly to a fusion protein having an H3N8 subtype of a horse influenza virus and a preparation method, application and vaccine. Background technique [0002] Equine Influenza, Ei) is an acute infectious disease caused by Equine Influenzavirus, EIV, which has acute and highly exposed to contagious features. The H3N8 subtype is a major epidemic plant, one of the hemp respiratory infectious diseases. [0003] The horsproof virus belongs to the orthomyxoviridae, the A-type influenza virus. It is a single-stranded negative, a single negative strand of a single-stranded negative, a virus having a pyramid membrane, a genome length of about 13.6 kb. There are many viral particles, most of which have a ball shape, which has a diameter of about 80-120 nm, and the filament is a few micrometers. The virus particle structure is mainly divided into three layers. The outermost membrane is composed...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
25 Jun 2021
Publication
CN109180820B
IPC
C07K19/00; C12N15/62; C12N15/85; C07K16/10; G01N33/569; A61K39/145; A61P31/16
CPC
A61K39/12; A61K2039/552; A61P31/16; C07K14/005; C07K16/1018; C12N15/85; C12N2760/16122; C12N2760/16134
Inventors
贺笋; 任立松